Merck, Upsher-Smith Settle 17-Year Pay-for-Delay Class Action Suit for $60.2 Million

Merck and Upsher-Smith Laboratories agreed to pay $60.2 million to settle a 17-year-long class action suit over plans to delay a generic potassium deficiency treatment — a case that survived three rounds of mediation, over four years of discovery, and a trip to the U.S. Supreme Court.
Source: Drug Industry Daily